Here are the presentation slides from the joint meeting of San Diego Clinical Research Network and Greater San Diego Area Chapter of ACRP on June 21.
Speaker: Jacqui Blem, Senior Director, Clinical Operations, Regulus Therapeutics
Patient centricity is one of the most basic, but least applied, new clinical research concepts (Marisa Co). Do you want your next clinical trial to be more “patient-centric”, but don’t know where to start? Jacqui Blem, Senior Director of Clinical Operations at Regulus Therapeutics, will discuss lessons learned managing a natural history study of Alport syndrome (AS). AS, a rare genetic kidney disease, causes a progressive loss of kidney function, which ultimately leads to end stage renal disease or death. Blem found that implementing tools that allowed her team to focus on the needs and interests of the study participants was a key strategy in the successful startup of the study.
Blem will provide practical guidance on designing a patient-centric study: what patient-centric strategies can be integrated into a protocol; how to operationalize different patient-centric strategies; and what factors to consider when implementing patient-centric strategies in a global environment. Attendees will become more confident about implementing patient-centric strategies into their future studies.
ABOUT THE SPEAKER. Jacqui Blem has been managing clinical studies at small biotechs, CROs, and large pharma companies for over 15 years. She has a breadth of experience managing the development of compounds from Phase I through Phase IV, and the development of In Vitro Diagnostics and medical devices. Jacqui is the Senior Director of Clinical Operations at Regulus Therapeutics, which is developing anti-microRNA therapeutics for Hepatitis C and kidney fibrosis. She is a frequent speaker at clinical research conferences on topics related to trial management.